Powder extensively hydrolysed formula (0913101) vs Glyc Pdr disc or non-ACBS carbohyd SfI metabol cond (091344)
Powder extensively hydrolysed formula (0913101) was dispensed 38,771.0× as often as Glyc Pdr disc or non-ACBS carbohyd SfI metabol cond (091344) in May 2026 — 38,771 items versus 1 in England.
Powder extensively hydrolysed formula (0913101) · May 2026
NHSBSA Prescription Cost Analysis
Glyc Pdr disc or non-ACBS carbohyd SfI metabol cond (091344) · May 2026
NHSBSA Prescription Cost Analysis
Figure 1. Powder extensively hydrolysed formula (0913101) versus Glyc Pdr disc or non-ACBS carbohyd SfI metabol cond (091344): national items dispensed by month
▬ Powder extensively hydrolysed formula (0913101) · ╌ Glyc Pdr disc or non-ACBS carbohyd SfI metabol cond (091344)
Source: NHSBSA Prescription Cost Analysis, to May 2026
| Measure | Powder extensively hydrolysed formula (0913101) | Glyc Pdr disc or non-ACBS carbohyd SfI metabol cond (091344) |
|---|---|---|
| Items, May 2026 | 38,771 | 1 |
| Items, last 12 months | 486,570 | 17 |
| Net ingredient cost, May 2026 | £2,918,919 | £117 |
See the full profile for Powder extensively hydrolysed formula (0913101) or Glyc Pdr disc or non-ACBS carbohyd SfI metabol cond (091344).